Abstract
In the past decade, the availability of data obtained from large-scale studies using molecular and genetic techniques has provided a much-improved picture of the main pathogenic pathways involved in the progression of leprosy. There is a clear clustering of genes encoding for hallmark immune response molecules, reinforcing the overall understanding of the immunopathogenic processes leading to leprosy susceptibility or to polarization between clinical phenotypes. Metabolic changes, cellular trafficking, and autophagy regulate the responses to confer protection and eliminate bacilli from the host. Alternatively, in hosts that are susceptible due to genetic and/or environmental conditions, immune cells fail to activate this protective program through the interference of M. leprae ultimately leading to disease development. Recent insights on the immunopathology of leprosy can pave the way for new diagnostics and personalized therapy based on the immune profile of the specific clinical form of the disease.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Nery JS, Ramond A, Pescarini JM, Alves A, Strina A, Ichihara MY, et al. Socioeconomic determinants of leprosy new case detection in the 100 million Brazilian cohort: a population-based linkage study. Lancet Glob Health. 2019;7:e1226–36. https://doi.org/10.1016/S2214-109X(19)30260-8.
Moet FJ, Meima A, Oskam L, Richardus JH. Risk factors for the development of clinical leprosy among contacts, and their relevance for targeted interventions. Lepr Rev. 2004;75:310–26. https://doi.org/10.47276/lr.75.4.310.
Hacker MA, Maria Sales A, Cristina Duppre N, Nunes Sarno E, Ozório Moraes M. Leprosy incidence and risk estimates in a 33-year contact cohort of leprosy patients. Sci Rep. 2021;11:1947. https://doi.org/10.1038/s41598-021-81643-4.
Richardus R, Alam K, Kundu K, Chandra Roy J, Zafar T, Chowdhury AS, et al. Effectiveness of single-dose rifampicin after BCG vaccination to prevent leprosy in close contacts of patients with newly diagnosed leprosy: a cluster randomized controlled trial. Int J Infect Dis. 2019;88:65–72. https://doi.org/10.1016/j.ijid.2019.08.035.
van Hooij A, van den Eeden SJF, Khatun M, Soren S, Franken KLMC, Chandra Roy J, et al. BCG-induced immunity profiles in household contacts of leprosy patients differentiate between protection and disease. Vaccine. 2021;39:7230–7. https://doi.org/10.1016/j.vaccine.2021.10.027.
Lázaro FP, Werneck RI, Mackert CCO, Cobat A, Prevedello FC, Pimentel RP, et al. A major gene controls leprosy susceptibility in a hyperendemic isolated population from north of Brazil. J Infect Dis. 2010;201:1598–605. https://doi.org/10.1086/652007.
Boisson-Dupuis S, Ramirez-Alejo N, Li Z, Patin E, Rao G, Kerner G, et al. Tuberculosis and impaired IL-23-dependent IFN-γ immunity in humans homozygous for a common TYK2 missense variant. Sci Immunol. 2018;3(30):eaau8714.
Fava VM, Dallmann-Sauer M, Schurr E. Genetics of leprosy: today and beyond. Hum Genet. 2020;139(6–7):835–46. https://doi.org/10.1007/s00439-019-02087-5.
Behr MA, Schurr E. A table for two. Nature. 2013;501:498–9. https://doi.org/10.1038/nature12555.
Teles RMB, Lu J, Tió-Coma M, Goulart IMB, Banu S, Hagge D, et al. Identification of a systemic interferon-γ inducible antimicrobial gene signature in leprosy patients undergoing reversal reaction. PLoS Negl Trop Dis. 2019;13:e0007764. https://doi.org/10.1371/journal.pntd.0007764.
Toledo Pinto TG, Batista-Silva LR, Medeiros RCA, Lara FA, Moraes MO. Type I interferons, autophagy and host metabolism in leprosy. Front Immunol. 2019;9:806. https://doi.org/10.3389/fimmu.2018.00806.
Santos M, dos Franco ES, da Ferreira PLC, Braga WSM. Borderline tuberculoid leprosy and type 1 leprosy reaction in a hepatitis C patient during treatment with interferon and ribavirin. An Bras Dermatol. 2013;88:109–12. https://doi.org/10.1590/abd1806-4841.20131986.
Tió-Coma M, Kiełbasa SM, van den Eeden SJF, Mei H, Roy JC, Wallinga J, et al. Blood RNA signature RISK4LEP predicts leprosy years before clinical onset. EBioMedicine. 2021;68:103379. https://doi.org/10.1016/j.ebiom.2021.103379.
Oliveira MF, Medeiros RCA, Mietto BS, Calvo TL, Mendonça APM, Rosa TLSA, et al. Reduction of host cell mitochondrial activity as Mycobacterium leprae’s strategy to evade host innate immunity. Immunol Rev. 2021;301:193–208. https://doi.org/10.1111/imr.12962.
Wang D, Zhang D-F, Li G-D, Bi R, Fan Y, Wu Y, et al. A pleiotropic effect of the APOE gene: association of APOE polymorphisms with multibacillary leprosy in Han Chinese from Southwest China. Br J Dermatol. 2018;178:931–9. https://doi.org/10.1111/bjd.16020.
Lobato LS, Rosa PS, Da Silva FJ, Da Silva NA, Da Silva MG, Nascimento DC, et al. Statins increase rifampin mycobactericidal effect. Antimicrob Agents Chemother. 2014;58(10):5766–74. https://doi.org/10.1128/C01826.13.
Masaki T, Qu J, Cholewa-Waclaw J, Burr K, Raaum R, Rambukkana A. Reprogramming adult Schwann cells to stem cell-like cells by leprosy bacilli promotes dissemination of infection. Cell. 2013;152:51–67. https://doi.org/10.1016/j.cell.2012.12.014.
Leal-Calvo T, Avanzi C, Mendes MA, Benjak A, Busso P, Pinheiro RO, et al. A new paradigm for leprosy diagnosis based on host gene expression. PLoS Pathog. 2021;17:e1009972. https://doi.org/10.1371/journal.ppat.1009972.
Leal-Calvo T, Moraes MO. Reanalysis and integration of public microarray datasets reveals novel host genes modulated in leprosy. Mol Gen Genom. 2020;295:1355–68. https://doi.org/10.1007/s00438-020-01705-6.
Hooij A, Geluk A. In search of biomarkers for leprosy by unraveling the host immune response to Mycobacterium leprae. Immunol Rev. 2021;301:175–92. https://doi.org/10.1111/imr.12966.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Moraes, M.O., Pinheiro, R.O., Geluk, A. (2023). Metabolic, Genetic and Immunological Mechanisms in Susceptibility to Leprosy. In: Deps, P.D. (eds) Hansen’s Disease. Springer, Cham. https://doi.org/10.1007/978-3-031-30893-2_8
Download citation
DOI: https://doi.org/10.1007/978-3-031-30893-2_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-30892-5
Online ISBN: 978-3-031-30893-2
eBook Packages: MedicineMedicine (R0)